FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1208391007: Bebtelovimab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4964121011 Bebtelovimab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4964122016 Bebtelovimab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bebtelovimab Is a Substance with antiviral mechanism of action (substance) true Inferred relationship Some
Bebtelovimab Is a Monoclonal antibody true Inferred relationship Some
Bebtelovimab This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bebtelovimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bebtelovimab Inferred relationship Some 1
Product containing only bebtelovimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bebtelovimab Inferred relationship Some 1
Bebtelovimab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bebtelovimab Inferred relationship Some 1
Bebtelovimab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bebtelovimab Inferred relationship Some 1
Product containing precisely bebtelovimab 87.5 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Bebtelovimab Inferred relationship Some 1
Product containing precisely bebtelovimab 87.5 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Bebtelovimab Inferred relationship Some 1
Administration of bebtelovimab Direct substance True Bebtelovimab Inferred relationship Some 1
Adverse reaction to bebtelovimab Causative agent True Bebtelovimab Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start